Verification of the EDA Concept Through an Assessment of Theoretical Failure Modes, Failure Mode Analysis, and Case Studies with Real Data - Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products - page 270

Fig. 9.20 OIP product “B”APSD changes in 24-month stability trial assessed by CI stage
groupings
Fig. 9.21 OIP product “B”APSD changes in 24-month stability trial assessed by movement in
FPM